News from jazz pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 19, 2014, 19:05 ET

Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (asparaginase Erwinia chrysanthemi)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous...

Dec 11, 2014, 16:05 ET

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the initiation of a rolling submission of a New Drug Application (NDA) to the United...

Dec 02, 2014, 16:05 ET

Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patients have been enrolled in a Phase 3 clinical trial to assess the...

Dec 02, 2014, 16:05 ET

Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present the results of a number needed to treat (NNT; an...

Nov 25, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...

Nov 06, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

Nov 04, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2014 and updated financial...

Oct 21, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 third quarter financial results on Tuesday, November 4,...

Aug 08, 2014, 06:30 ET

Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), priced...

Aug 06, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to...

Aug 05, 2014, 16:05 ET

Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter ended June 30, 2014 and updated financial...

Aug 05, 2014, 16:01 ET

Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of rights to defibrotide in the United States (U.S.)...

Aug 04, 2014, 16:10 ET

Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Canaccord Genuity...

Jul 22, 2014, 16:05 ET

Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 second quarter financial results on Tuesday, August 5,...

Jul 02, 2014, 08:00 ET

Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has signed a definitive agreement with Sigma-Tau Pharmaceuticals, Inc....

Jun 02, 2014, 14:40 ET

Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a...

May 27, 2014, 16:05 ET

Jazz Pharmaceuticals To Present Data On Compound In Sleep Pipeline During APSS Annual SLEEP Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that new data for the investigational compound JZP-110 (previously ADX-N05) will...

May 19, 2014, 14:00 ET

Jazz Pharmaceuticals Names Russell J. Cox To Position Of Chief Operating Officer

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Russell J. Cox to the newly created position of chief operating officer...

May 13, 2014, 18:15 ET

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...

May 08, 2014, 16:05 ET

Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2014 and reaffirmed and updated...